Genstar Names Keith Martino to Strategic Advisory Board
Genstar Names Keith Martino to Strategic Advisory Board
Experienced Pharma Executive to Advise on the Firm's Healthcare Investments
经验丰富的制药高管将就公司的医疗保健投资提供建议
SAN FRANCISCO, April 30, 2024 /PRNewswire/ -- Genstar Capital, a leading private equity firm focused on investments in targeted segments of the healthcare, financial services, industrials, and software industries, today announced the appointment of experienced pharma executive Keith Martino to its team of operational experts serving on its Strategic Advisory Board. He will advise the Genstar team in its healthcare vertical.
旧金山，2024年4月30日 /PRNewswire/ — 专注于投资医疗保健、金融服务、工业和软件行业目标细分市场的领先私募股权公司Genstar Capital今天宣布，任命经验丰富的制药业高管基思·马蒂诺加入其战略顾问委员会的运营专家团队。他将为Genstar团队提供医疗保健领域的建议。
Mr. Martino has diverse experience working in pharma, consulting, private equity and venture capital. He spent 17 years in pharma with commercial roles at Abbott, AbbVie and Shire (formerly Baxalta) and later was an operating partner with the Vistria Group and Chief Strategy Officer at CareMetx. Most recently, he managed four pharma services businesses within Cardinal Health. Mr. Martino is a graduate of Northwestern University with a B.A. degree in Economics and received his M.B.A. from the University of Chicago Booth School of Business.
Martino先生在制药、咨询、私募股权和风险投资领域拥有丰富的经验。他在制药行业工作了17年，曾在雅培、艾伯维和夏尔（前身为巴萨尔塔）担任商业职务，后来成为Vistria集团的运营合伙人和CareMetX的首席战略官。最近，他管理了Cardinal Health旗下的四家制药服务业务。Martino 先生毕业于西北大学，获得经济学学士学位，并获得芝加哥大学布斯商学院工商管理硕士学位。
Scott Niehaus, Director of Genstar Capital, said, "Keith is highly regarded in the pharma industry and has extensive background across the value chain including working with private equity. Keith brings a tremendous network and complementary skill set, which in partnership with Genstar's existing advisors make him well suited to further build Genstar's healthcare focus. We look forward to Keith's guidance in evaluating new healthcare investment opportunities and advising portfolio companies as a board member." Mr. Martino was named to the Board of Genstar portfolio company Signant Health.
Genstar Capital董事斯科特·尼豪斯表示：“基思在制药行业备受推崇，在价值链中拥有丰富的背景，包括与私募股权合作。Keith拥有庞大的人脉和互补的技能，与Genstar的现有顾问合作，这使他非常适合进一步发展Genstar的医疗保健重点。我们期待Keith在评估新的医疗保健投资机会以及作为董事会成员为投资组合公司提供建议方面提供指导。”马蒂诺先生被任命为Genstar投资组合公司Signant Health的董事会成员。
A cornerstone of its investment thesis, Genstar's SAB consists of talented current and former C-level operational experts from many of the world's leading companies and industries in which the firm invests.
作为其投资理念的基石，Genstar的SAB由来自公司投资的许多世界领先公司和行业的现任和前任C级运营专家组成。
About Genstar Capital
Genstar Capital () is a leading private equity firm that has been actively investing in high quality companies for over 30 years. Based in San Francisco, Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar currently has approximately $49 billion of assets under management and targets investments focused on targeted segments of the financial services, industrials, software, and healthcare industries.
关于Genstar Capital
Genstar Capital () 是一家领先的私募股权公司，30多年来一直积极投资高质量的公司。Genstar总部位于旧金山，与其管理团队和战略顾问网络合作，将其投资组合公司转变为行业领先的业务。Genstar目前管理着约490亿美元的资产，目标投资集中在金融服务、工业、软件和医疗保健行业的目标细分市场。
Contact: Chris Tofalli
Chris Tofalli Public Relations
914-834-4334
[email protected]
联系人：克里斯·托法利
克里斯·托法利公共关系
914-834-4334
[电子邮件保护]
SOURCE Genstar Capital Management, LLC
来源 Genstar 资本管理有限责任公司